|
Match
|
Document |
Document Title |
|
|
US20100310586 |
IDIOTYPIC VACCINE
The invention concerns the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non HCV-related lymphoproliferations, in particular the use of... |
|
|
US20110293723 |
SYNTHETIC NANOCARRIER COMBINATION VACCINES
Disclosed are dosage forms and related methods, that include a first population of synthetic nanocarriers that have one or more first antigens coupled to them, one or more second antigens that are... |
|
|
US20110182995 |
MEDICAL AND DENTAL BIOMATERIAL AND METHOD OF USE FOR THE SAME
The embodiments herein provide a dental and medical biomaterial and its use for sealing and/or filling the tooth and bone cavities. In the embodiments herein, the calcium salt, calcium oxide,... |
|
|
US20120087944 |
ORAL VACCINE FAST-DISSOLVING DOSAGE FORM USING STARCH
A fast-dissolving dosage form (FDDF) for the delivery of a vaccine is prepared using a formulation containing a starch, optionally, along with at least one additional matrix forming agent,... |
|
|
US20130122027 |
NEOEPITOPE DETECTION OF DISEASE USING PROTEIN ARRAYS
A biosensor for use in detecting the presence of diseases, the biosensor comprising a detector for detecting a presence of at least one marker indicative of a specific disease. A method of... |
|
|
US20150023950 |
2,6-Diaminopyridine Compounds Suitable for Treating Diseases Associated with Amyloid or Amyloid-Like Proteins or for Treating or Preventing Ocular Diseases or Conditions Associated with a Pathological Abnormality/Change in the Tissue of the Visual System
The present invention relates to 2,6-diaminopyridine compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein and of diseases or... |
|
|
US20110293701 |
MULTIVALENT SYNTHETIC NANOCARRIER VACCINES
The invention relates, at least in part, to compositions comprising populations of synthetic nanocarriers that comprise different sets of antigens as well as related methods. |
|
|
US20120171230 |
ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISM
The anti-pathogen vaccine of the present invention is produced in recombinant bacteria and/or transgenic plants and then administered through standard vaccine introduction method or through the... |
|
|
US20120201857 |
Transdermal delivery system for therapeutics
The present invention provides a method and product for transdermal delivery of therapeutics, including neurotoxins and methods for use thereof. The method and system comprises pharmaceutical... |
|
|
US20120276109 |
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS
Disclosed are synthetic nanocarrier compositions, and related methods, comprising therapeutic protein APC presentable antigens and immunosuppressants that provide tolerogenic immune responses... |
|
|
US20110076323 |
VACCINE FOR ALZHEIMER'S DISEASE
Compositions and methods for prevention and treatment of Alzheimer's disease utilize a combination of amyloid-beta protein or a fragment thereof and a heat shock protein or a fragment thereof. |
|
|
US20140010885 |
SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM
A self-assembling nanoparticle drug delivery system for the delivery of various bioactive agents including peptides, proteins, nucleic acids or synthetic chemical drugs is provided. The... |
|
|
US20150071879 |
Stabilization of Aqueous Compositions of Proteins with Displacement Buffers
An aqueous composition having increased protein stability is obtained by: a. determining a pH at which the protein has stability at the desired temperature; b. adding to the composition at least... |
|
|
US20110293657 |
ENCAPSULATED VACCINES FOR THE ORAL VACCINATION AND BOOSTERING OF FISH AND OTHER ANIMALS
The invention relates to a composition comprising a pharmaceutically active agent and a bioadhesive delivery system that provides for the oral delivery of a vaccine to animals, particularly... |
|
|
US20120301498 |
CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS
Disclosed are synthetic nanocarrier compositions that provide controlled release of immunosuppressants as well as related methods. The synthetic nanocarrier compositions may also include antigen... |
|
|
US20150044240 |
P53 VACCINES FOR THE TREATMENT OF CANCERS
The present invention relates to immunotherapy methods for treating hyperproliferative disease in humans, particularly to hyperproliferative disease that is refractory to therapy. More... |
|
|
US20110243975 |
TRANSFORMED SOYBEAN PLANT WHICH ACCUMULATES VACCINE, AND USE THEREOF
A transformed soybean plant having a gene encoding a modified seed storage protein introduced therein, obtained by inserting a gene encoding an Alzheimer's disease vaccine to a variable region(s)... |
|
|
US20120093857 |
Vaccination and Immunotherapy as New Therapeutic Modalities in the Treatment of Glaucoma
This invention provides a method whereby a vaccine, particularly a vaccine based on a prophylactic or therapeutic AIDS/HIV vaccine, or other immune-reactive substance is administered to produce an... |
|
|
US20130243689 |
MULTI-COMPARTMENTAL MACROPHAGE DELIVERY
Disclosed are multi-compartmental nanoparticulate systems for imaging as well as the diagnosis, monitoring, and treatment of inflammation and/or disease. These multicompartmental nanoparticulate... |
|
|
US20100297108 |
METHOD OF PROVIDING PATIENT SPECIFIC IMMUNE RESPONSE IN AMYLOIDOSES AND PROTEIN AGGREGATION DISORDERS
A novel treatment of Alzheimer's disease and other disorders involving protein misfolding or aggregation is provided by enhancing or sustaining an antibody response against predominantly directed... |
|
|
US20140314798 |
METHOD TO MEASURE INFLAMMATION IN THE CONJUNCTIVA OF PATIENTS WITH TEAR DYSFUNCTION
The present invention concerns methods and compositions for treatment and determination of the presence or likelihood of an individual to have an ocular surface inflammation. In specific... |
|
|
US20120040010 |
MICROPARTICULATED VACCINES FOR THE ORAL OR NASAL VACCINATION AND BOOSTERING OF ANIMALS INCLUDING FISH
The invention relates to a composition and a method for manufacturing semi-dry or dry particles containing a mucoadhesive polymer and a bioactive agent such as, but not limited to, an Immunogenic... |
|
|
US20110280893 |
SYNTHETIC LIPID A DERIVATIVE
The invention provides functionalized monosaccharides and disaccharides suitable for use in synthesizing a lipid A derivative, as well as methods for synthesizing and using a synthetic lipid A... |
|
|
US20120093841 |
Her2 DNA Vaccine as Adjunct Treatment for Cancers in Companion Animals
The application discloses therapeutic vaccines based upon the “pING” DNA plasmid vector expressing the gene encoding the rat Her2 protein. Vaccines according to the instant disclosure are used as... |
|
|
US20110064723 |
Formulation for room temperature stabilization of a live attenuated bacterial vaccine
This invention provides methods and compositions for stabilizing proteins and vaccines in dried formulations. In particular, a cavitation method and compositions of preparing a dried vaccine are... |
|
|
US20140170177 |
Food Supplement Having High Immunological Value, Based On A Protein Matrix
The invention relates to a food supplement having high immunological value, based on a protein matrix, i.e. a food compound with high immunological value, based on the mixture of four protein... |
|
|
US20110286932 |
OPTICAL METHOD FOR THE DETECTION OF ALZHEIMER'S DISEASE
The present subject matter relates to a non-invasive optical imaging method for monitoring early pathological events specific to Alzheimer's disease (AD), such as the development, amount and... |
|
|
US20120195928 |
VACCINES AND METHODS FOR USING THE SAME
Compositions comprising one or more isolated nucleic acid molecules that encode an immunogen in combination with one or more of CTACK protein, TECK protein, MEC protein and functional fragments... |
|
|
US20140271815 |
HEAT-AND FREEZE-STABLE VACCINES AND METHODS OF MAKING AND USING SAME
A vaccine adjuvant composition comprising: a lipid selected from the group consisting of: Dipalmitoyl phosphatidlcholine (DPPC), Dipalmitoyl phosphatidylglycerol (DPPG), Dioleoyl... |
|
|
US20110110979 |
METHOD AND VACCINE FOR OPTIMIZING THE SPECIFIC IMMUNE RESPONSES
The present invention relates to a method for treating an infection or disease or lesion, in particular an HPV infection. Furthermore, it relates to a vaccine for treating a Human Papillomavirus... |
|
|
US20120128703 |
Aminopterin Dosage Forms and Methods for Inflammatory Disorders
There is disclosed dosage forms and methods for treating a patient with an inflammatory disorder with a therapeutically effective amount of aminopterin, or a pharmaceutically acceptable salt... |
|
|
US20110200589 |
DECONVOLUTION METHOD
The present invention relates generally to novel applications in combating infectious disease, cancer, allergy and autoimmune diseases. In one aspect, the invention relates to identifying one or... |
|
|
US20120244222 |
OSMOTIC MEDIATED RELEASE SYNTHETIC NANOCARRIERS
This invention relates, at least in part, to osmotic mediated release barrier-free synthetic nanocarriers and methods of production and use. |
|
|
US20140023669 |
USE OF A HYPOALLERGENIC CEREAL COMPOSITION FOR INDUCING SPECIFIC ORAL TOLERANCE
A partial hydrolysate of cereal protein for use in inducing specific oral tolerance in a young mammal with allergy to said cereal protein, wherein the hydrolysate has a degree of hydrolysis... |
|
|
US20110256214 |
SINGLE-TIME VACCINES
The invention is related to the field of vaccines. The technical objective is to obtain novel unitemporal therapeutic and prophylactic vaccines (single time vaccination strategy) using... |
|
|
US20120059358 |
DNA VACCINES ENCODING HEAT SHOCK PROTEINS
The present invention is related to a method of treating a T cell-mediated inflammatory autoimmune disease by administering to an individual in need thereof an immunogenic composition comprising a... |
|
|
US20140248320 |
ADJUVANTED INFLUENZA B VIRUS VACCINES FOR PEDIATRIC PRIMING
The influenza B strain is epidemiologically relevant in the pediatric population. Immunogenic priming of children with influenza B vaccine adjuvanted with an oil-in-water emulsion primes an immune... |
|
|
US20120311729 |
Immunomodulatory Methods and Systems for Treatment and/or Prevention of Atherosclerosis
Immunostimulatory methods and systems for treating or preventing atherosclerosis and/or a condition associated thereto in an individual. |
|
|
US20120027806 |
DOSE SELECTION OF ADJUVANTED SYNTHETIC NANOCARRIERS
Disclosed are synthetic nanocarrier compositions with coupled adjuvant compositions as well as related methods. |
|
|
US20140322268 |
SYNTHETIC GLUCOPYRANOSYL LIPID ADJUVANTS
Compounds, particularly, glucopyranosyl lipid adjuvant (GLA) compounds, having the following structure (I) are provided: or a pharmaceutically acceptable salt thereof, wherein L1, L2, L3, L4, L5,... |
|
|
US20100310602 |
SYNTHETIC GLUCOPYRANOSYL LIPID ADJUVANTS
Compounds, particularly, glucopyranosyl lipid adjuvant (GLA) compounds, having the following structure (I) are provided: or a pharmaceutically acceptable salt thereof, wherein L1, L2, L3, L4, L5,... |
|
|
US20150044241 |
CONTRACEPTIVE VACCINES FOR MAMMALS
The invention provides a contraceptive vaccine for a female recipient of a target species of mammals including a composition of at least one of a plurality of granulosa cells and a plurality of... |
|
|
US20130045180 |
VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME
Improved vaccines which include a nucleotide sequence that encodes immunomodulating protein operably linked to regulatory elements are disclosed. The improved vaccines include DNA vaccines,... |
|
|
US20120195852 |
VACCINES, IMMUNOTHERAPEUTICS AND METHODS FOR USING THE SAME
Improved vaccines which include a nucleotide sequence that encodes immunomodulating protein operably linked to regulatory elements are disclosed. The improved vaccines include DNA vaccines,... |
|
|
US20140234347 |
METHODS OF USING BIOMARKERS FOR PREDICTING THE OUTCOME OF AN IMMUNOTHERAPY AGAINST CANCER
The present invention relates to methods for predicting the effect of an immunotherapy against cancer in a patient based on new biomarkers. The present invention furthermore relates to a prognosis... |
|
|
US20130273120 |
METHODS AND COMPOSITIONS FOR INTRANASAL DELIVERY
Provided herein are methods for generating dry vaccine powder formulations. Dry vaccine powder formulations can be used for intranasal delivery. Also provided are methods for stimulating local... |
|
|
US20130129781 |
METHODS AND COMPOSITIONS FOR INTRANASAL DELIVERY
Provided herein are methods for generating dry vaccine powder formulations. Dry vaccine powder formulations can be used for intranasal delivery. Also provided are methods for stimulating local... |
|
|
US20120128712 |
VACCINE DIRECTED AGAINST PORCINE PLEUROPNEUMONIA AND A METHOD TO OBTAIN SUCH A VACCINE
The present invention pertains to a vaccine directed against porcine pleuropneumonia, comprising lipopolysaccharide, wherein the vaccine comprises a polymyxin to reduce symptoms of an endotoxic... |
|
|
US20120148660 |
CONJUGATES OF SYNTHETIC TLR AGONISTS AND USES THEREFOR
The invention provides TLR agonists and conjugates thereof useful in vaccines and to prevent, inhibit or treat a variety of disorders including pathogen infection and asthma. |
|
|
US20110311518 |
NOVEL SYNTHETIC AGONISTS OF TLR9
The invention relates to synthetic chemical compositions that are useful for modulation of Toll-Like Receptor (TLR)-mediated immune responses. In particular, the invention relates to agonists of... |